Medicina
Departamento
University of Basel
Basilea, SuizaPublicaciones en colaboración con investigadores/as de University of Basel (47)
2024
-
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients
The Lancet Infectious Diseases, Vol. 24, Núm. 1, pp. e59-e68
2023
-
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 7, pp. 1376-1382
-
Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms
Journal of clinical microbiology, Vol. 61, Núm. 4, pp. e0104922
-
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
Brain : a journal of neurology, Vol. 146, Núm. 11, pp. 4633-4644
2022
-
Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial
Frontiers in Oncology, Vol. 12
-
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103
-
Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial
European Journal of Neurology, Vol. 29, Núm. 3, pp. 790-801
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058
-
Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin
Respiratory Research, Vol. 23, Núm. 1
-
Procalcitonina es superior a recuento linfocitario, índice neutrófilo/linfocito y proteína C reactiva para la predicción de mortalidad a 30 días de pacientes con COVID-19 en el servicio de urgencias
Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 34, Núm. 2, pp. 119-127
2021
-
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
Annals of Oncology, Vol. 32, Núm. 10, pp. 1216-1235
-
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
Journal of Neurology, Vol. 268, Núm. 11, pp. 3961-3968
-
Expected medium- And long-term impact of the COVID-19 outbreak in oncology
JCO Global Oncology, Vol. 7, pp. 162-172
-
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
Journal of Hepatology, Vol. 74, Núm. 5, pp. 1097-1108
-
Peanut-induced anaphylaxis in children and adolescents: Data from the European Anaphylaxis Registry
Allergy, Vol. 76, Núm. 5, pp. 1517-1527
2020
-
Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers
Blood, Vol. 136, Núm. 6, pp. 698-714
-
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy
Journal of Thoracic Oncology, Vol. 15, Núm. 5, pp. 709-740
-
Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis
Frontiers in Pediatrics, Vol. 8
2019
-
Anaphylaxis in Elderly Patients-Data From the European Anaphylaxis Registry
Frontiers in immunology, Vol. 10, pp. 750